This study will assess the causes of discontinuity of tuberculosis treatment and strategies to improve the…
Category: Studies
A phase 3, open-label study to evaluate switching from a TDF-containing combination regimen to a TAF-containing combination single tablet regimen (STR) in virologically-suppressed, HIV-1 positive subjects
Randomized, open-label, multicenter, active-controlled study to evaluate the safety and efficacy of virologically suppressed subjects who…
LiveRLife
This is a pilot, healthy life campaign for HCV among ex- and current illicit drug users.
Maraviroc in kids
An open-label, multicenter, multiple-dose pharmacokinetic, safety and efficacy trial of maraviroc in combination with optimized background…
A phase 3 multicenter, double-blind, randomized, active comparator-controlled clinical trial to evaluate the safety and efficacy of reformulated Raltegravir 1200 mg once daily versus Raltegravir 400 mg twice daily, each in combination with TRUVADA™, in treatment-naïve HIV-1 infected subjects
This study will evaluate the safety and efficacy of reformulated raltegravir (MK-0518) 1200 mg once daily…
Stop C
This program will help develop and propel HCV treatment.
Safety and efficacy of switching to a FDC of BIC/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in virologically suppressed HIV-1 infected women
This is a phase 3, randomized, open label study to evaluate the efficacy of switching to…
A Multicenter Study of the International Network for Strategic Initiatives in Global HIV Trials
A Multicenter Study of the International Network for Strategic Initiatives in Global HIV Trials
Long-term outcome of HBV in Thai cohort of HIV/HBV co-infected patients
This is a long-term cohort and cross sectional study to assess the outcome of treatment using…
TDF renal toxicity cohort
This study will assess the incidence and predictor of TDF associated nephrotoxicity and pharmacokinetic of TDF…
The TREAT Asia pediatric HIV Observational Database (TApHOD)
This study is an HIV pediatric HIV observational database collecting HIV clinical data from 6 countries…
Determinants of resilience in youth with HIV infection and youth affected by HIV
This is a prospective observational cohort study that will identify the determinants of resilience in HIV-infected…
A phase 3, randomized, double-blind study to evaluate the safety and efficacy of GF-9350-boosted Atazanavir versus Ritonavir-boosted Atazanavir each administered with Emtricitabine/Tenofovir disoproxil fumarate in HIV-1 infected, antiretroviral treatment-naïve adults
This is a multicenter phase 3, randomized, double-blind, active-controlled study to evaluate the safety and efficacy…
A phase 2/3, open-label study of the pharmacokinetics, safety, and antiviral activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) single tablet regimen (STR) in HIV-1 infected antiretroviral treatment-naive adolescents
This is an open-label, multicenter, two-part, single-arm study of the pharmacokinetics, safety, tolerability, and antiviral activity…
The neurodevelopment in normal children in Cambodia and Thailand
This cohort collects of the neurodevelopmental data from normal children in Cambodia and Thailand
